Atlas Trials

Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia

Clinical trial NCT07292259 · COMPLETED

Trial details

NCT number
NCT07292259
Sponsor
Pakistan Blood and Marrow Transplant (PBMT) Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Transfusion Dependent Beta Thalassemia
Start date
2024-01-01
Primary completion
2025-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.